Computerized prescribing: Building the electronic infrastructure for better medication usage

JAMA

Volumn 279, Issue 13, 1998, Pages 1024-1029

  Schiff, Gordon D ^a   Rucker, T Donald ^b  

^a Jr Hospital of Cook County   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SYSTEM; DOSE CALCULATION; HEALTH CARE POLICY; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCREENING; TREATMENT OUTCOME;

EID: 0032054130     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.13.1024     Document Type: Review

References (110)

1. Rucker TD. Drug use: data, sources and limitation. JAMA. 1974;230:889-890.
2. Wyatt J, Walton R. Computer based prescribing. BMJ. 1995;311:1181-1182.
3. Bates DW, Kuperman G, Teich JM. Computerized physician order entry and quality of care. Qual Manage Health Care. Summer 1994;2:18-27.
4. Bates DW, Cullen DJ, Laird N, et al, for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.
5. Top-priority actions for preventing adverse drug events in hospitals: recommendations of an expert panel. Am J Health Syst Pharm. 1996;53:747-751.
6. Chin TL. Using automation to reduce medication errors. Health Data Manage. July 1997;5:74-79.
7. Weed LL. New connections between medical knowledge and patient care. BMJ. 1997;315:231-235.
8. Schneider R, LaBatt EP. Computerized system for physician order entry. Am J Health Syst Pharm. 1995;52:2184-2186.
9. Glabman M. Hold the phone: going online with prescriptions. Am Coll Phys Observer. October 1996;16:8-9.
10. Muirhead G. Physician-pharmacy links making rapid headway. Drug Topics. September 16, 1996; 140:61.
11. Ellinoy BJ. Fax fiction. Am J Hasp Pharm. 1989; 46:1549-1550.
12. Sitting DF, Steed WW. Computer-based physician order entry: the state of the art. J Am Med Inform Assoc. 1994;1:108-123.
13. Felkey BG. Health system informatics. Am J Health Syst Pharm. 1997;54:274-280.
14. Rucker TD, Schiff GD. Drug formularies: myths-in-formation. Med Care. 1990;28:928-942.
15. The computer will see you now [editorial]. Lancet. 1996;347:1127.
16. The Sowerby Unit for Primary Care Informatics. Prodigy Interim Report. Newcastle upon Tyne, England: School of Health Sciences, University of Newcastle upon Tyne; 1996. Prodigy publication 24.
17. Soumerai S, Lipton HL. Computer-based drug utilization review: risk, benefit or boondoggle? N Engl J Med. 1995;332:1641-1644.
18. Gray BH, Perreira KM. Medical professionalism under managed care: the pros and cons of utilization review. Health Aff (Millwood). 1997;16: 106-124.
19. Balas EA, Boren SA, Brown GD, Ewigman BG, Mitchell JA, Perkoff GT. Effect of physician profiling on utilization. J Gen Intern Med. 1996;11:584-590.
20. Lipton HL, Bird JA. Drug utilization review in ambulatory settings: state of the science and directions for outcomes research. Med Care. 1993;31: 1069-1082.
21. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antifective agents. N Engl J Med. 1998;338:232-238.
22. Shea S, DuMouchell W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc. 1996;3:399-409.
23. Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med. 1994;154:878-884.
24. McDonald CJ, Hui SL, Smith DM, et al. Reminders to physicians from an introspective computer medical record: a 2-year randomized trial. Ann Intern Med, 1984:100:130-138.
25. Balas EA, Austin SM, Mitchell JA, Ewigman BG, Bopp KD, Brown GD. The clinical value of computerized information services. Arch Fam Med. 1996;3:271-278.
26. Walton RT, Gierl C, Yudkin P, Mistry H, Vessey MP, Fox J. Evaluation of computer support for prescribing (CAPSULE) using simulated cases. BMJ. 1997;315:791-795.
27. Schriger DL, Baraff LJ, Rogers WH, Cretin S. Implementation of clinical guidelines using a computer charting system: effect on the initial care of health care workers exposed to body fluids. JAMA. 1997;278:1585-1590.
28. Grimshaw J, Eccles M, Russell I. Developing clinically valid practice guidelines. J Eval Clin Pract. September 1995;1:37-48.
29. Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Carter AO. Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. Can Med Assoc J. 1997;156:1715-1723.
30. Hayward RS, Wilson MC, Tunis SR, Guyatt GH, Moore KA, Bass EB. Practice guidelines: what are internists looking for? J Gen Intern Med. 1996;11: 176-178.
31. Weingarten S. Practice guidelines and prediction rules should be subject to careful clinical testing. JAMA. 1997;277:1977-1978.
32. McDonald CJ. The barriers to electronic medical record systems and how to overcome them. J Am Med Inform Assoc. 1997;4:213-221.
33. Miller RA, Gardner RM. Recommendations for responsible monitoring and regulation of clinical software systems. J Am Med Inform Assoc. 1997; 4:442-457.
34. Talking about drug treatments: who should say what to whom? Drug Ther Bull. May 19,1994;32:35-37.
35. Schiff GD. Patient education: beyond the boundaries. In: U.S.P. Open Conference on Patient Education. Rockville, Md: US Pharmacopeia Inc; 1993: 13-18.
36. Mullen PD. Compliance becomes concordance: making a change in terminology produces a change in behavior. BMJ. 1997;314:691-692.
37. Effective Dissemination of Health and Clinical Information to Consumers. Washington, DC: Agency for Health Care Policy and Research; 1995. AHCPR publication 92-0030.
38. Prescription Medicine Compliance: A Review of the Baseline of Knowledge. Washington, DC: National Council on Patient Information and Education; 1995.
39. Chewning B, Sleath B. Medication decision-making and management: a client-centered model. Soc Sci Med. 1996;42:389-398.
40. Gibbs S, Waters WE, George CF. Communicating with patients about medicine. JR Soc Med 1990; 83:292-296.
41. Healthy People 2000 Review 1995-96. Hyattsville, Md: National Center for Health Statistics, US Dept of Health and Human Services; 1996.
42. Headden S. Danger at the drugstore. US News and World Report. August 26, 1996:47-53.
43. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA. 1996;275:1086.
44. Hampton CE, Balson AB, Schiff GD. Do ask, don't tell: failure to communicate drug allergies recorded in outpatient medical record to a pharmacy computer [abstract]. J Invest Med. 1997;45:311A.
45. Szolovits P, Doyle J, Long WJ. Guardian angel: patient-centered health information systems. Toward Electronic Patient Record. March 1996;4(8): 8-11.
46. Cannon B, Lee M. Clinical lab tests: application to daily practice. J Am Pharm Assoc. 1996;NS36: 668-679.
47. +. Paper presented at: Examining Errors in Health Care: Developing a Prevention, Education and Research Agenda; October 14, 1996; Annenberg Center for Health Sciences, Rancho Mirage, Calif.
48. Schiff GD, Hegde HK, LaCloche L, Hryhorczuk DO. Inpatient theophylline toxicity: preventable factors. Ann Intern Med. 1991;114:748-753.
49. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-306.
50. Siwicki B. Enterprise networks: strategies for integrated delivery systems. Health Data Manage. February 1997;5:54-66.
51. Poikonen J. Arden Syntax: the emerging standard language for representing medical knowledge in computer systems. Am J Health Syst Pharm. 1997;54:281-284.
52. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med. 1996; 124:884-890.
53. Overhage JM, Tierney W, Zhou XH, McDonald CJ. A randomized trial of "corollary orders" to prevent errors of omission. J Am Med Inform Assoc. 1997;4:364-375.
54. Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW. Appropriateness of antiepileptic drug level monitoring. JAMA. 1995;274:1622-1626.
55. Berwick DM. Controlling variation in health care: a consultation from Walter Shewhart. Med Care. 1991;29:1212-1225.
56. Barker KN, Allan EL. Research on drug-use-system errors. Am J Health Syst Pharm. 1995;52: 400-403.
57. Zeroing in on medication errors [editorial]. Lancet. 1997;349:369.
58. Bates DW. Medication errors: how common are they and what can be done to prevent them? Drug Saf. 1996;15:303-310.
59. Legier JD. Physicians' accuracy in manual computation. MD Comput. 1990;3:155-159.
60. Cohen MR, Anderson RW, Attilio RM, Green L, Muller RJ, Pruemer JM. Preventing medication errors in cancer chemotherapy. Am J Health Syst Pharm. 1996;53:737-746.
61. Powsner SM, Tufte ER. Graphical summary of patient status. Lancet. 1994;344:386-389.
62. Wijnands MJ, van't Hof MA, van Leeuwen MA, van Rijswijk MH, van de Putte LB, van Riel R. Long-term second-line treatment: a prospective drug survival study. Br J Rheumatol. 1992;31:253-258.
63. Andrade SE, Platt R, Gottlieb LK, Saperia GM, Walker AM. Discontinuations of antihyperlipidemic drug therapy: assessment by means of automated databases. Pharmacoepidemiol Drug Safety. 1996; 5:113-120.
64. Lyons RF, Rumore MM, Merola MR. An analysis of drug information desired by the patient: are patients being told everything they wish to know under OBRA '90? J Clin Pharm Ther. 1996;21:221-228.
65. Food and Drug Administration. Proposed rules: prescription drug product labeling: medication guide requirements. Federal Register. 1995;60: 44182-44252.
66. Nightingale SL. Written patient information on prescription drugs: the evolution of government and voluntary programs in the United States. Int J Technol Assess Health Care. 1995;11:399-409.
67. Morris LA, Tabak ER, Gondek K. Counseling patient about prescribed medication: 12 year trends. Med Care. 1997;35:996-1007.
68. Thompson CA. Opinions on useful patient drug information aired at FDA workshop: opposition to MedGuide proposal runs strong. Am J Health Syst Pharm. 1996;53:712-714.
69. Lipton HL, Byrns PJ, Soumerai SB, Chrischilles EA. Pharmacists as agents of change for rational drug therapy. Int J Technol Assess Health Care. 1995;11:485-508.
70. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277:312-317.
71. Bradley CP, Taylor RJ, Blenkinsopp A. Developing prescribing in primary care. BMJ. 1997;314: 744-747.
72. Lamb GC, Green SS, Heron J. Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med. 1994; 154:2753-2756.
73. Kessler DA, for the Working Group. Introducing MedWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993;269:2765-2768.
74. Faich GA. U.S. adverse drug reaction surveillance 1989-1994. Pharmacoepidemiol Drug Safety. 1996;5:393-398.
75. Schiff GD. Red man syndrome and the red button system: where next for inpatient adverse drug reaction reporting? Jt Comm J Qual Improv. 1995; 21:549-552.
76. Martin R, Hilton S, Richards N. Monitoring the frequency of side effects of drugs: reasons for stopping drugs could be recorded in general practice. BMJ. 1996;312:1418-1419.
77. Lortie FM. Postmarketing surveillance of adverse drug reactions: problems and solutions. Can Med Assoc J. 1986;135:27-32.
78. Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl J Med. 1993;329:2029-2032.
79. Rovelli F, Tognoni G. The health service as a laboratory. Lancet. 1996;348:169-170.
80. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350:1097-1099.
81. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med. 1989;320: 53-56.
82. Miles P. Quality improvement in health care: the year behind, the year ahead. Jt Comm J Qual Improv. 1995;21:32-43.
83. Martin J. The Great Transition: Using the Seven Disciplines of Enterprise Engineering to Align People, Technology, and Strategy. New York, NY: AMACOM; 1995.
84. Committee on Improving the Medical Record, Institute of Medicine. The Computer-Based Patient Record: An Essential Tool for Health Care. Washington, DC: National Academy Press; 1991.
85. Tognoni G, Bonati M. Second-generation clinical pharmacology. Lancet. 1986;2:1028-1029.
86. Leape LL. Error in medicine. JAMA. 1994;272: 1851-1857.
87. Hart JT. Two paths for medical practice. Lancet. 1992;340:772-775.
88. Amatayakul M. Making the case for electronic records. Health Data Manage. May 1997;5:56-63.
89. Tuttle MS. Medical informatics challenges of the 1990s: acknowledging secular change. J Am Med Inform Assoc. 1997;4:322-324.
90. Elson RB, Faughnan JG, Connelly DP. An industrial process view of information delivery to support clinical decision making: implications for systems design and process measures. J Am Med Inform Assoc. 1997;4:266-278.
91. Doyle E. Not exactly what the doctor ordered: few prescription-management programs fill all of an internist's needs. Am Coll Phys Observer. July 1995; 15:7-8.
92. Blobel B. Comparison, evaluation and integration of different middleware approaches involving COBRA, DHE and HL71. Toward Electronic Patient Rec. May 1997;5(10):3-11.
93. McDonald CJ, Overhage JM, Dexter P, Takesue BY, Dwyer DM. A framework for capturing clinical data sets from computerized sources. Ann Intern Med. 1997;127:675-682.
94. Wolinsky H. Resolution due in medical software regulation. Ann Intern Med. 1997;127:953-954.
95. Council on Competitiveness. Highway to Health: Transforming U.S. Health Care in the Information Age. Washington, DC: Council on Comptetitiveness; 1996. Available at: http://nii.nist.gov/pubs /coc_hghwy_to_hlth/toc.html. Accessed March 1, 1998.
96. Maruyama H, Nawa Y, Noda S. Commercialization of disease management. Lancet. 1996;347:1768-1769.
97. Curtiss FR. Lessons learned from projects in disease management in ambulatory care. Am J Health Syst Pharm. 1997;54:2217-2229.
98. McDonald CJ, Hammond WE. Standard formats for electronic transfer of clinical data. Ann Intern Med. 1989;110:333-335.
99. van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med. 1993;119: 1036-1041.
100. Reason J. Human Error. New York, NY: Cambridge University Press; 1990.
101. Schulman KA, Rubenstein LE, Abernethy DR, Seils DM, Sulmasy DP. The effect of pharmaceutical benefits managers: is it being evaluated? Ann Intern Med. 1996;124:906-913.
102. McCarthy R. Precipitating factors for pharmaceutical firms. Business Health, 1997;15(No. 5; suppl):39-43.
103. International Society for Pharmacoepidemiology. Data Privacy, Medical Record Confidentiality, and Research in the Interest of Public Health. Washington, DC: International Society for Pharmacoepidemiology; 1997.
104. Cross MA. Drug companies see opportunities in health information technology. Health Data Manage. October 1996;4:70-74.
105. Marsa L. Prescription for Profit. New York, NY: Charles Scribner's Sons; 1997.
106. McCarthy R. Linkingphysicians, pharmacists, and PBMs electronically. Drug Benefit Trends. October 1997;9:36-39.
107. Davis P, ed. Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs. Oxford, England: Oxford University Press; 1996.
108. Gabriel ER. Need for standards in medical communication. Top Health Rec Manage. May 1991; 11:27-36.
109. Garibaldi RA. Computers and the quality of care: a clinician's perspective. N Engl J Med. 1998; 338:259-260.
110. Relman AS. An institute for health-care evaluation. N Engl J Med. 1982;306:669-670.